170 related articles for article (PubMed ID: 32143728)
1. How can health economics be used in the design and analysis of adaptive clinical trials? A qualitative analysis.
Flight L; Julious S; Brennan A; Todd S; Hind D
Trials; 2020 Mar; 21(1):252. PubMed ID: 32143728
[TBL] [Abstract][Full Text] [Related]
2. A Review of Clinical Trials With an Adaptive Design and Health Economic Analysis.
Flight L; Arshad F; Barnsley R; Patel K; Julious S; Brennan A; Todd S
Value Health; 2019 Apr; 22(4):391-398. PubMed ID: 30975389
[TBL] [Abstract][Full Text] [Related]
3. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
4. The use of economic evaluations in NHS decision-making: a review and empirical investigation.
Williams I; McIver S; Moore D; Bryan S
Health Technol Assess; 2008 Apr; 12(7):iii, ix-x, 1-175. PubMed ID: 18373906
[TBL] [Abstract][Full Text] [Related]
5. Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development.
Claxton K; Palmer S; Longworth L; Bojke L; Griffin S; McKenna C; Soares M; Spackman E; Youn J
Health Technol Assess; 2012; 16(46):1-323. PubMed ID: 23177626
[TBL] [Abstract][Full Text] [Related]
6. Missing steps in a staircase: a qualitative study of the perspectives of key stakeholders on the use of adaptive designs in confirmatory trials.
Dimairo M; Boote J; Julious SA; Nicholl JP; Todd S
Trials; 2015 Sep; 16():430. PubMed ID: 26416387
[TBL] [Abstract][Full Text] [Related]
7. Risk-based, 6-monthly and 24-monthly dental check-ups for adults: the INTERVAL three-arm RCT.
Clarkson JE; Pitts NB; Goulao B; Boyers D; Ramsay CR; Floate R; Braid HJ; Fee PA; Ord FS; Worthington HV; van der Pol M; Young L; Freeman R; Gouick J; Humphris GM; Mitchell FE; McDonald AM; Norrie JD; Sim K; Douglas G; Ricketts D
Health Technol Assess; 2020 Nov; 24(60):1-138. PubMed ID: 33215986
[TBL] [Abstract][Full Text] [Related]
8. Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency.
Collignon O; Koenig F; Koch A; Hemmings RJ; Pétavy F; Saint-Raymond A; Papaluca-Amati M; Posch M
Trials; 2018 Nov; 19(1):642. PubMed ID: 30454061
[TBL] [Abstract][Full Text] [Related]
9. The impact of the National Institute for Health Research Health Technology Assessment programme, 2003-13: a multimethod evaluation.
Guthrie S; Bienkowska-Gibbs T; Manville C; Pollitt A; Kirtley A; Wooding S
Health Technol Assess; 2015 Aug; 19(67):1-291. PubMed ID: 26307643
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. A conceptual model for the development process of confirmatory adaptive clinical trials within an emergency research network.
Mawocha SC; Fetters MD; Legocki LJ; Guetterman TC; Frederiksen S; Barsan WG; Lewis RJ; Berry DA; Meurer WJ
Clin Trials; 2017 Jun; 14(3):246-254. PubMed ID: 28135827
[TBL] [Abstract][Full Text] [Related]
12. Reviewing the evidence to inform the population of cost-effectiveness models within health technology assessments.
Kaltenthaler E; Tappenden P; Paisley S
Value Health; 2013; 16(5):830-6. PubMed ID: 23947977
[TBL] [Abstract][Full Text] [Related]
13. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
[TBL] [Abstract][Full Text] [Related]
14. Generalisability in economic evaluation studies in healthcare: a review and case studies.
Sculpher MJ; Pang FS; Manca A; Drummond MF; Golder S; Urdahl H; Davies LM; Eastwood A
Health Technol Assess; 2004 Dec; 8(49):iii-iv, 1-192. PubMed ID: 15544708
[TBL] [Abstract][Full Text] [Related]
15. Healthcare stakeholders' perceptions and experiences of factors affecting the implementation of critical care telemedicine (CCT): qualitative evidence synthesis.
Xyrichis A; Iliopoulou K; Mackintosh NJ; Bench S; Terblanche M; Philippou J; Sandall J
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD012876. PubMed ID: 33599282
[TBL] [Abstract][Full Text] [Related]
16. Individual health services.
Schnell-Inderst P; Hunger T; Hintringer K; Schwarzer R; Seifert-Klauss VR; Gothe H; Wasem J; Siebert U
GMS Health Technol Assess; 2011; 7():Doc05. PubMed ID: 21966301
[TBL] [Abstract][Full Text] [Related]
17. Health technology assessment in Australia: a role for clinical registries?
Scott AM
Aust Health Rev; 2017 Mar; 41(1):19-25. PubMed ID: 27028134
[TBL] [Abstract][Full Text] [Related]
18. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.
Murphy P; Glynn D; Dias S; Hodgson R; Claxton L; Beresford L; Cooper K; Tappenden P; Ennis K; Grosso A; Wright K; Cantrell A; Stevenson M; Palmer S
Health Technol Assess; 2021 Dec; 25(76):1-228. PubMed ID: 34990339
[TBL] [Abstract][Full Text] [Related]
19. Health technology assessment and priority setting for universal health coverage: a qualitative study of stakeholders' capacity, needs, policy areas of demand and perspectives in Nigeria.
Uzochukwu BSC; Okeke C; O'Brien N; Ruiz F; Sombie I; Hollingworth S
Global Health; 2020 Jul; 16(1):58. PubMed ID: 32641066
[TBL] [Abstract][Full Text] [Related]
20. Modelling tool to support decision-making in the NHS Health Check programme: workshops, systematic review and co-production with users.
O'Flaherty M; Lloyd-Williams F; Capewell S; Boland A; Maden M; Collins B; Bandosz P; Hyseni L; Kypridemos C
Health Technol Assess; 2021 May; 25(35):1-234. PubMed ID: 34076574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]